Avidity Biosciences
RNA
#1838
Rank
โ‚น979.96 B
Marketcap
โ‚น6,504
Share price
0.32%
Change (1 day)
136.05%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: โ‚น979.96 Billion

As of December 2025 Avidity Biosciences has a market cap of โ‚น979.96 Billion. This makes Avidity Biosciences the world's 1838th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น979.96 B217.98%
2024โ‚น308.17 B416.63%
2023โ‚น59.65 B-51.12%
2022โ‚น122.04 B47.09%
2021โ‚น82.97 B18.47%
2020โ‚น70.03 B

End of Day market cap according to different sources

On Dec 13th, 2025 the market cap of Avidity Biosciences was reported to be:

โ‚น979.96 Billion
by Nasdaq info icon info icon
โ‚น979.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
โ‚น549.87 B-43.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น74.33 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น204.27 B-79.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น262.86 B-73.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚น12.01 B-98.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚น989.79 B 1.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.307 T 1,257.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.917 T 810.02%๐Ÿ‡ฌ๐Ÿ‡ง UK